| mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.1 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
| mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.2 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.2 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |